SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-006520
Filing Date
2023-04-24
Accepted
2023-04-24 16:05:19
Documents
12
Period of Report
2023-04-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230421x8k.htm   iXBRL 8-K 38281
  Complete submission text file 0001558370-23-006520.txt   158426

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20230421.xsd EX-101.SCH 3151
3 EX-101.LAB tmb-20230421_lab.xml EX-101.LAB 15918
4 EX-101.PRE tmb-20230421_pre.xml EX-101.PRE 10334
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230421x8k_htm.xml XML 4879
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 23840032
SIC: 2834 Pharmaceutical Preparations